Cannabidiol, or CBD, is a key compound in cannabis plants, though it doesn’t cause marijuana’s high.
CBD is being added to foods, drinks and creams. The evidence for many wellness claims about CBD is thin, though it is a key ingredient in one prescription drug.
Business Insider reports regularly on the growing business of CBD. You can read all our stories by subscribing to BI Prime and sign up for our new cannabis newsletter Cultivated here.
Cannabidiol, or CBD, is popping up everywhere, from creams to coffee to prescriptions. CBD is one of the key compounds in cannabis plants, though it doesn’t cause marijuana’s characteristic high. It’s being touted as a treatment for all kinds of ailments, but the evidence for some uses is thin.
Meanwhile, CBD is already a $1 billion industry, and some on Wall Street think it could reach $16 billion, aided in part by a recent change in US law that made some CBD legal.
The CBD boom on Wall Street
Square has started working with a select group of CBD startups while other payments rivals shy away from the trendy substance
CBD companies were courted hard by a unit of US Bank — but they got ghosted despite having a 100% legal business
A top venture investor that’s backed companies like Bird and TheRealReal explains why CBD is primed to explode
Food, Science, and Medicine:
A groundbreaking drug made from cannabis has brought hope for kids with rare seizure disorders. We talked to parents, doctors, and the company’s CEO to find out if it lives up the hype.
We’re at the start of a new era for marijuana-based medicine, according to the CEO behind the first prescription CBD drug
Wall Street thinks CBD could be a $16 billion industry by 2025. Here’s what …read more
Source:: Business Insider